Physician profile
Muhammad Abdullah
NPI 1053312645
$1,166.83
in general payments reported to CMS, 2019-2025
12 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.35 · 2020: $19.01 · 2021: $74.57 · 2022: $159 · 2023: $205 · 2024: $320 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $422.52 | 2021-2025 | Hemospray, Fusion |
| Olympus America INC. | $156.11 | 2022-2024 | Endoclot Phs, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Aurinia Pharma U.S., INC. | $145.57 | 2023 | Lupkynis |
| Boston Scientific Corporation | $135.47 | 2019-2025 | Jagtome Rx 39, Spyglass |
| Gilead Sciences, INC. | $69.00 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.73 | 2025 | |
| Janssen Biotech, INC. | $51.23 | 2025 | Tremfya |
| Lilly USA, LLC | $35.44 | 2024 | Jardiance |
| Csl Behring | $28.55 | 2023 | Kcentra |
| Conmed Corporation | $25.00 | 2025 | Conmed Biliary |
| Steris Corporation | $18.56 | 2021 | |
| Abbvie INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.